Driving innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

6
May

6. May 2025 — Register here

Implementing the European Health Data Space (EHDS): The Next Steps

Join EUCOPE on 6 May 2025 for an insightful and dynamic webinar on the next steps in implementing the European Health Data Space (EHDS) Regulation. We’ll focus on its secondary use and the implications for the life sciences sector. In this 60-minute session, experts from… read more

8
May

8. May 2025

EUCOPE Workshop | How to Prepare for EU HTA from a Payer Perspective

Join our workshop to explore the impact of EU HTA on pharmaceutical market access in Europe. Senior executives will gain strategic insights from key markets—France, Germany, and Spain—through expert analysis and real-life case studies. Learn how to navigate EU HTA challenges and leverage real-world data… read more

Our Events Section

News & Updates

Joint EUCOPE – IFPMA statement to support the adoption of the WHA Resolution on Rare Diseases

    16 April 2025, Geneva –  The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the innovative pharmaceutical industry worldwide, and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), representing small and mid-sized innovative health technology companies in Europe, welcome and echo the Call… read more

EUCOPE Member Spotlight: Q&A with Corinne Schmitz – Chairman, Founder & CEO at Azurbio Pharma

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In April, we spoke with Corinne Schmitz Chairman, Founder & CEO at Azurbio Pharma. Corinne Schmitz is an accomplished… read more

EUCOPE statement on the European Commission’s Strategic Dialogue with the pharmaceutical sector and the potential of tariffs

Brussels, 8 April, 2025 – This morning, EUCOPE’s Secretary General, Dr Alexander Natz, joined the European Commission’s Strategic Dialogue with the pharmaceutical sector. We thank Commission President von der Leyen for convening this meeting as an important opportunity to share the perspective of the innovative… read more

Health Stakeholders advocate for enhanced collaboration in European Health Data Space (EHDS) Implementation

Brussels, 10 March – A coalition of 39 leading representatives from the European health community has published a joint statement welcoming the publication of the European Health Data Space (EHDS) regulation in the EU’s Official Journal. The group underscores the need to promptly establish an… read more

EUCOPE’s Sounds of Science Podcast – Episode #20 Tackling Medicine Shortages: The Role of EU Policies

Sounds of Science – episode 20 Tackling Medicine Shortages: the role of EU Policies Medicine shortages are a growing challenge across Europe, impacting patients, healthcare systems, and companies alike. But how is the EU tackling this issue? What role do EU policies and the upcoming… read more

EUCOPE Member Spotlight: Q&A with Sarah Boyce, President and Chief Executive Officer at Avidity Biosciences

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Sarah Boyce, President and Chief Executive Officer at Avidity Biosciences. Tell us about your… read more

EUCOPE’s Sounds of Science Podcast – Episode #19 Building a competitive pharmaceutical ecosystem: EUCOPE’s call to EU Institutions

EUCOPE’s Sounds of Science Podcast – Episode 19 Building a competitive pharmaceutical ecosystem: EUCOPE’s call to EU Institutions In this episode of Sounds of Science, we invited our members, Toon Digneffe and Enrico Piccinini, to discuss with Alexander Natz how the EU’s competitiveness strategies may… read more

EUCOPE Member Spotlight: Q&A with Antoine Bernasconi, Executive VP, Chief Commercial Officer Europe & International at SERB Pharmaceuticals

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In January, we spoke with Antoine Bernasconi, Executive VP, Chief Commercial Officer Europe & International at SERB Phamaceuticals. Tell… read more

EUCOPE Member Spotlight: Q&A with Catherine Owen Adams, CEO of Acadia Pharmaceuticals

Regularly, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. For the December edition, we spoke with Catherine Owen Adams, CEO of Acadia Pharmaceuticals. Tell us about your organization and… read more

EVENT RECAP – What Drives Life Sciences Investment in the EU and the Future Impact of the Pharma Package?

On November 14th, EUCOPE together with FTI Consulting EU hosted the event “What Drives Life Sciences Investment in the EU and the Future Impact of the Pharma Package”, to mark the launch of the report, ‘’The Economic Lens: Understanding What Makes the EU Attractive for… read more

... or browse news by Tag

Patients Rare Disease Medicines Regulatory innovation Access Health Members Research COVID19 Events Commission OMP podcast ATMPs HTA Medical Devices EMA Digital IVDR pharma biotech EU Health Job Posting European Commission Brexit MDR AdvancedDxs genomics HERA EHDS Life Science European Parliament Safety PharmaPackage competitiveness SoHO Regulation data act Supply GDPR MEDTECH clinical trial EU Institutions Publication RNA

Our News Section

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership